FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies.
Moffatt
S D
SD
Department of Surgery, Addenbrooke's Hospital, Cambridge, United Kingdom.
Metcalfe
S M
SM
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology*; D016827:CD8 Antigens / Q000276:immunology*; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D051379:Mice; D008807:Mice, Inbred BALB C; D008808:Mice, Inbred CBA; D016559:Tacrolimus / Q000097:blood / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D016827:CD8 Antigens; D016572:Cyclosporine; D016559:Tacrolimus